Europe Prefilled Syringes Market

Europe Prefilled Syringes Market Size 

The Europe Prefilled Syringes Market was valued at USD 1.23 billion in 2024. The Europe Prefilled Syringes Market is expected to have 5.77 % CAGR from 2025 to 2033 and be worth USD 2.04 billion by 2033 from USD 1.30 billion in 2025.  

The growing diabetic patient population across Europe drives the European prefilled syringes market growth. According to the data published by IDF Diabetes Atlas, an estimated 61 million people in Europe had diabetes in 2024, which was also 1 in every 11 adults. Most type-1 diabetic people use insulin injections to manage the glucose levels in the body. These insulin dosage intakes are different for different people based on the glucose levels in the body. Healthcare providers prescribe the dosage of insulin for diabetic people. At certain times, people may increase or decrease the dosage due to insufficient free time leading to dosage errors resulting in severe conditions. To avoid this type of situation among diabetic people, healthcare providers prefer prefilled syringes, supporting the European market growth.

The rising home healthcare for diabetes management by many people in Europe is anticipated to fuel the market’s growth rate in Europe. Owing to the increased heart and autoimmune disorders among the population, patients need to take regular self-medication to avoid critical situations. These types of people are preferred to use prefilled syringes for treatment.

Growing innovation in the prefilled syringes by the researcher is expected to boost Europe's market’s growth rate. The key market participants focus primarily on developing prefilled syringes with the cap system and the different types of material based on the drug inside it. They also focus on manufacturing disposable prefilled syringes, which can be discarded for environmental safety. In addition, rising demand for biosimilar and biologics and an increasing number of product launches are further propelling the prefilled syringes market growth in Europe.

However, the lack of prefilled syringes in pharmacy stores in some countries of Europe is the primary factor restraining market growth. In addition, strict government rules, lack of awareness in some areas, increasing availability of alternative options, and high production costs further hinder European market growth.

SEGMENTAL ANALYSIS

By Material Insights

The glass segment had the leading share of the European market in 2024. However, the plastic segment is anticipated to grow at the fastest CAGR during the forecast period.

By Type Insights

The safety segment is predicted to register the fastest CAGR in the European prefilled syringes market during the forecast period.

By Design Insights

The single-chamber segment is anticipated to hold a major share of the European prefilled syringes market during the forecast period.

By Application Insights

The monoclonal antibodies segment is predicted to capture the leading share of the European market during the forecast period.

By Distribution Channel Insights

The hospital segment is predicted to occupy the leading share of the European market during the forecast period.

REGIONAL ANALYSIS

Geographically, the Europe region accounted for the second largest share of the worldwide market in 2024 and is anticipated to grow at a notable CAGR during the forecast period owing to the increasing usage of prefilled syringes for various chronic diseases and increasing awareness about prefilled syringes among the European population.

The UK prefilled syringes market is anticipated to hold the major share of the European market during the forecast period owing to the growing number of manufacturing centers to produce prefilled syringes. Furthermore, major pharmaceutical companies focus on developing prefilled syringes due to increasing demand. In addition, the growing advertisements by the key market participants to spread awareness about prefilled syringes are contributing to the growth of the UK market.

The German prefilled syringes market is predicted to witness a healthy CAGR during the forecast period. In 2024, Schreiner MediPharm, a German researcher, developed new prefilled syringes with the help of radio frequency identification technology. Using this technology to prefill syringes, an intelligent label is attached to the syringes, which helps optimize hospital inventory management and patient care and documentation. Additionally, increasing investment by the private and public sectors also helps to increase the production of prefilled syringes in this country.

Italy is another promising regional market for prefilled syringes in Europe and is estimated to showcase a healthy CAGR in the coming years. To prevent drug usage in the operation rooms, most hospitals in Italy use prefilled syringes to save time taken to manually fill the drug into the syringes and inject it into the patients without any dosage errors. Furthermore, to avoid needle stick injuries, doctors and healthcare nurses prefer to use prefilled syringes with specific dosages for the patient to reduce the injury rate and spread of the infection between persons.

KEY MARKET PLAYERS

Companies like Becton Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Ompi, Catalent, Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation & MedPro Inc. are playing a leading role in the Europe Prefilled Syringes Market.

MARKET SEGMENTATION

This research report on the Europe prefilled syringes market has been segmented and sub-segmented into the following categories

By Material 

• Glass

• Plastic

By Type 

• Conventional
• Safety

By Design 

• Single-Chamber
• Dual-Chamber

By Application 

• Vaccines
• Monoclonal Antibodies

By Distribution Channel 

• Hospitals
• Ambulatory Surgical Centres
• Mail-Order Pharmacies

By Country 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe